Stay Informed on Corporate Sustainability

Author: Archie Villaflores

United States-based Merck has agreed to acquire Terns Pharmaceuticals for $6.7 billion (€5.7 billion), gaining TERN-701, an investigational oral therapy for chronic myeloid leukemia. The transaction strengthens Merck's pharmaceutical manufacturing excellence capabilities in hematology.

Author: Archie Villaflores

United States-based Amgen has invested $407 million (€353 million) in capital expenditure at its Dun Laoghaire manufacturing facility over two years. The investment strengthens Ireland's pharmaceutical manufacturing excellence capabilities and supports workforce expansion plans.

Author: Archie Villaflores

United States-based Steris is the preferred bidder to acquire Cardinal Health's Tullamore facility closing in April. The transaction preserves pharmaceutical manufacturing excellence operations in County Offaly and is expected to create new positions.

Author: Archie Villaflores

Ireland's FASPM 2026-2029 resets medicine pricing and reimbursement rules for the pharmaceutical sector. A new four-year framework between the State, IPHA, and MFI accelerates new medicine access timelines while imposing rigorous pricing discipline across all categories.

Author: Archie Villaflores

Looking back at last year’s highlights, Almac Pharma Services claimed both the Pharma Supplier of the Year and Pharma Facility of the Year awards at the Pharma Industry Awards 2025 for a breadth of achievement that spans cutting-edge facility development, agile expertise, and strategic growth across Ireland's pharmaceutical landscape. The double recognition reflects the high bar the Pharma Industry Awards set for entries across supplier and facility categories as the 2026 cycle approaches.

Author: Jed Nykolle Harme

Honoured for world-class research excellence in 2025, the National Institute for Bioprocessing Research and Training won Pharma Research Centre of the Year at the Pharma Industry Awards 2025. The institute's GMP-simulated plant and global policy influence showcase leadership on a national and international scale. NIBRT's achievement sets a global benchmark for bioprocessing innovation, combining cutting-edge discovery with real-world application as the sector looks toward 2026. The recognition underscores the institute's role as a powerhouse of collaboration and sustainability driving industry transformation.

Author: Jed Nykolle Harme

Ireland's pharma sector hit record highs in 2025 for exports, employment and tax receipts. As GLP-1 drug demand surges, the industry's role as Ireland's economic backbone has never been stronger.

Author: Jed Nykolle Harme

US-based clinical-stage biotech Skyhawk Therapeutics has appointed Aaron Deves as chief commercial officer to lead the commercialisation of SKY-0515 for Huntington's disease. Deves brings over 30 years of neurological drug commercialisation experience.

Author: Jed Nykolle Harme

UK consultancy CF has partnered with Canadian firm Medlior Health Outcomes Research to generate real-world evidence for global life science sponsors. The alliance spans NHS England and Alberta datasets.

Author: Jed Nykolle Harme

Derry-based start-up LifeCellsNI has raised £590,000 (€689,000) to build Northern Ireland's first HTA-licensed stem cell storage and biobank facility. Cleanroom installation is under way ahead of an April launch.